U.S. drug regulators have now approved the COVID-19 vaccines made by Pfizer and Moderna, but the approved versions of the vaccines don’t appear to be available yet in the United States. The Food and Drug Administration (FDA) approved Moderna’s jab on Jan. 31, about five months after it approved Pfizer’s shot. The approved vaccines are known as Spikevax and Comirnaty. In a letter to Moderna, the FDA said that there is not “sufficient” supply of either approved vaccine. “Although Spikevax (COVID-19 Vaccine, mRNA) and Comirnaty (COVID-19 Vaccine, mRNA) are approved to prevent COVID-19 in certain individuals within the scope of the Moderna COVID-19 Vaccine authorization, there is not sufficient approved vaccine available for distribution to this population in its entirety at” this time, the Jan. 31 missive states. Comirnaty was not being distributed in the United States as of October, The Epoch Times found. Queries were sent to officials in …